Cellular changes as a marker of depressive fatigue

Researchers from the University of Queensland and the University of Minnesota have recorded for the first time the same changes in the molecules responsible for fatigue in both brain tissue and blood cells. In depression, cells work differently than previously thought. Scientists have identified fundamental disturbances in the energy metabolism of cells in young people with major depressive disorder (MDD). Specific changes in the level of adenosine triphosphate (ATP), a molecule that serves as the primary source of energy for the body, have been detected.

Cellular changes as a marker of depressive fatigue

At rest, in patients with diagnosed depression, cells produce an excessive amount of energy molecules. When faced with stressful situations, these same cells demonstrate a reduced ability to increase their energy capacity. These findings suggest that in the early stages of depression, mitochondria (the structures responsible for energy generation) are overworked and have limited reserves to adapt to high demands.

This state of cellular exhaustion directly correlates with the clinical symptoms of depression. When the brain and body are unable to respond properly to increased energy demand, patients develop conditions such as:

  • decreased motivation and interest in activities
  • depressed mood
  • slowed cognitive functions
  • chronic physical fatigue

Fatigue is one of the most common and difficult symptoms of major depressive disorder to treat. Until now, progress in treatment has been hampered by a lack of understanding of the biological mechanisms of this condition. The discovery of an energy marker in blood tests gives hope for the development of early diagnostic methods that will allow doctors to detect depression before the development of severe forms of the disease.

This study confirms that depression is not only a psychological, but also a deep biological process that affects energy metabolism throughout the body. The scientists emphasize that each patient has unique biological characteristics, so in the future, diagnosing ATP levels could be the key to personalized treatment that is much more effective than standard approaches.

The discovery also aims to reduce the stigma associated with the disease: understanding that depression changes the way cells function at the molecular level shifts the discussion from the realm of willpower to objective medicine.

Published

March, 2026

Category

Science

Duration of reading

2-3 minutes

Share

Source

Scientific Journal Translational Psychiatry. Article:  ATP bioenergetics and fatigue in young adults with and without major depression

Don’t miss the most important science and health updates!

Subscribe to our newsletter and get the most important news straight to your inbox

Send us a message